301301
Antidepressivos e ansiolíticos em doentes cardíacos
30. Rasmussen SL, Overo KF, Tanghoj P. Cardiac safety of citalopram: prospective trials and
retrospective analyses. J Clin Psychopharmacol. 1999; 19:407‑15.
31. Lespérance F, Frasure‑Smith N, Koszycki D et al. Effects of citalopram and interpersonal psy-
chotherapy on depression in patients with coronary artery disease. The Canadian Cardiac
Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial. J Am
Med Assoc. 2007; 297: 367‑79.
32. Astrom‑Lilja C, Odeberg JM, Ekman E, et al. Drug‑induced torsades de pointes: a review
of the Swedish pharmacovigilance database. Pharmacoepidemiol Drug Saf. 2008; 17:587‑92.
33. Strikk JJ, Honig A, Lousberg R, et al. Cardiac side‑effects of two selective serotonin reuptake
inhibitors in middle‑aged and elderly depressed patients. Int Clin Psychopharmacol. 1998;
13: 263‑7.
34. Wyeth Pharmaceuticals. Summary of Product Characteristics. Exefor. 2009.
-
cines.org.uk.
35. Letsas K, Korantzopoulos P, Pappas L, el al. QT interval prolongation associated with venla-
faxine administration. Int J Cardiol. 2006; 109:116‑17.
36. Colucci VJ, Berry BD. Heart failure worsening and exacerbation after venlafaxine and dulo-
xetine therapy. Ann Pharmacother. 2008; 42:882‑7.
37. Schatzberg AF. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the
treatment of major depressive disorder. J Clin Psychiatry. 2003; 64 Suppl 13: 30‑7.
38. Montgomery SA. Safety of mirtazapine: a review. Int Clin Psychopharmacol. 1995; 10 Suppl
4:37‑45.
39. Honig A, Kuyper AM, Schene AH, et al. Treatment of post‑myocardial infarction depressive
disorder: a randomized, placebo‑controlled trial with mirtazapine. Psychosom Med. 2007;
69: 606‑613.
40. Winkler D, Ortner R, Pjrek E, et al. Trazodone‑induced cardiac arrhythmias: a report of two
cases. Hum Psychopharmacol. 2006; 21:61‑2.
41. Warrington SJ, Padgham C, Lader M. The cardiovascular effects of antidepressants. Psychol
Med Monogr Suppl. 1989; 16:i‑40.
42. Dattilo PB, Nordin C. Prolonged QT associated with an overdose of trazodone. J Clin
Psychiatry. 2007; 68:1309‑10.
43. Dolder CR, Nelson M, Snider M. Agomelatine treatment of major depressive disorder. The
Ann Pharmacother. 2008; 42:1822‑31.
44. Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin
reutake inhibitors in overdose compared to tricyclic antidepressants. QJM. 2003; 96:369‑74.
45. Waring WS, Wallace WA. Acute myocarditis after massive phenelzineu overdose. Euro J Clin
Pharmacol. 2007; 63:1007‑9.
